Dionsysus Digital Health

Dionysus Digital Health

Description

Dionsysus Digital Health is developing a platform of proprietary epigenetic tests to predict the risk of hormonal depressions like postpartum depression (PPD) and related mood disorders associated with PMS and menopause in women; a key market differentiation for our test is the ability to provide precision medical insight to enable an individual’s anti-depressant responder status.

Information

Contact Andrea Cubitt
Title CEO